COVID-19 and immunothrombosis: emerging understanding and clinical management.

British Journal of Haematology
Rebecca J ShawCheng-Hock Toh

Abstract

The COVID-19 pandemic has been the most significant health crisis in recent global history. Early studies from Wuhan highlighted COVID-19-associated coagulopathy and a significant association with mortality was soon recognised. As research continues across the world, more evidence is emerging of the cross-talk between the innate immune system, coagulation activation and inflammation. Immunothrombosis has been demonstrated to play a key role in the pathophysiology of severe COVID-19, with extracellular histones and neutrophil extracellular traps detected in the plasma and cardiopulmonary tissues of critically ill patients. Targeting the components of immunothrombosis is becoming an important factor in the treatment of patients with COVID-19 infection. Recent studies report outcomes of intermediate and therapeutic anticoagulation in hospitalised patients with varying severities of COVID-19 disease, including optimal dosing and associated bleeding risks. Immunomodulatory therapies, including corticosteroids and IL-6 receptor antagonists, have been demonstrated to significantly reduce mortality in COVID-19 patients. As the pandemic continues, more studies are required to understand the driving factors and upstream mechanisms for co...Continue Reading

References

Jul 11, 2001·Critical Care Medicine·J F DhainautC Vinsonneau
Jun 21, 2002·Nature·Michael A CrackowerJosef M Penninger
Apr 16, 2003·The New England Journal of Medicine·Nelson LeeJoseph J Y Sung
Apr 16, 2003·Annals of the Rheumatic Diseases·R A Asherson, R Cervera
Mar 6, 2004·Science·Volker BrinkmannArturo Zychlinsky
Mar 20, 2004·Clinical and Experimental Immunology·C K WongJ J Y Sung
Nov 12, 2005·British Journal of Haematology·Charles T Esmon
Aug 31, 2007·Thrombosis Research·Edward Young
Nov 23, 2007·Journal of Leukocyte Biology·Marcel SchoutenTom van der Poll
Oct 27, 2009·Nature Medicine·Jun XuCharles T Esmon
Jan 30, 2010·Critical Care Medicine·Marcel Levi, Tom van der Poll
Apr 27, 2012·International Journal of Peptides·Chris Tikellis, M C Thomas
Dec 12, 2012·Nature Reviews. Immunology·Bernd Engelmann, Steffen Massberg
Dec 5, 2014·Critical Care Medicine·Wendy LimUNKNOWN PROphylaxis for ThromboEmbolism in Critical Care Trial Investigators
Feb 24, 2015·Journal of Intensive Care·Takashi Ito
May 6, 2015·The American Journal of Medicine·M Todd GreeneVineet Chopra
Jul 8, 2015·Journal of Thrombosis and Haemostasis : JTH·T J GouldP C Liaw
Apr 12, 2016·British Journal of Haematology·Yasir Alhamdi, Cheng-Hock Toh
Nov 26, 2016·Thrombosis Research·Marcel Levi, Tom van der Poll
Dec 21, 2016·Respiration; International Review of Thoracic Diseases·Frantzeska FrantzeskakiStylianos E Orfanos
Jan 12, 2019·Seminars in Thrombosis and Hemostasis·Elodie LaridanSimon F De Meyer
Aug 15, 2019·Journal of Thrombosis and Haemostasis : JTH·Toshiaki IbaUNKNOWN Scientific and Standardization Committee on DIC, and the Scientific and Standardization Committee on Perioperative and Criti
Nov 22, 2019·Frontiers in Immunology·Nonantzin Beristain-CovarrubiasAdam F Cunningham
Feb 20, 2020·Journal of Thrombosis and Haemostasis : JTH·Ning TangZiyong Sun
Feb 23, 2020·The Lancet. Respiratory Medicine·Zhe XuFu-Sheng Wang
Feb 29, 2020·The New England Journal of Medicine·Wei-Jie GuanUNKNOWN China Medical Treatment Expert Group for Covid-19
Mar 28, 2020·Journal of the European Academy of Dermatology and Venereology : JEADV·S Recalcati
Apr 4, 2020·Circulation·Justin A FriedGabriel Sayer
Apr 5, 2020·Thrombosis and Haemostasis·Giuseppe Lippi, Emmanuel J Favaloro
Apr 9, 2020·Journal of Thrombosis and Haemostasis : JTH·Janice WangChristopher D Barrett
Apr 16, 2020·Journal of Medical Virology·Jieyun ZhuChunling Zhao
Apr 16, 2020·Journal of the European Academy of Dermatology and Venereology : JEADV·A EstébanezM D Ramón
Apr 17, 2020·Signal Transduction and Targeted Therapy·Li TanHongming Miao
Apr 17, 2020·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Ruoqing LiJianqiang Ding
Apr 18, 2020·Translational Research : the Journal of Laboratory and Clinical Medicine·Cynthia MagroJeffrey Laurence

❮ Previous
Next ❯

Citations

Jun 12, 2021·British Journal of Haematology·George GoshuaAlfred I Lee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

EBioMedicine
Daigo Nakazawa, Akihiro Ishizu
Current Opinion in Hematology
Irina PortierFrederik Denorme
Intensive Care Medicine
James S O'DonnellIgnacio Martin-Loeches
© 2021 Meta ULC. All rights reserved